BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35459206)

  • 1. Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation.
    Xu C; Shen Y; Shi Y; Zhang M; Zhou L
    Cancer Cell Int; 2022 Apr; 22(1):161. PubMed ID: 35459206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.
    Song S; Liu J; Zhang M; Gao X; Sun W; Liu P; Wang Y; Li J
    Bioengineered; 2022 Feb; 13(2):2762-2776. PubMed ID: 35040374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
    Xiang P; Sun Y; Fang Z; Yan K; Fan Y
    Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.
    Feng Y; Wu L
    Int J Clin Exp Pathol; 2020; 13(1):99-106. PubMed ID: 32055278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
    Yue Q; Meng L; Jia B; Han W
    Exp Ther Med; 2020 Jul; 20(1):436-446. PubMed ID: 32537008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer.
    Xiong H; Hu M; Huang H; Gong J; Wu J; Zhang H
    Transl Cancer Res; 2019 Oct; 8(6):2242-2251. PubMed ID: 35116977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.
    Wang L; Wen X; Luan F; Fu T; Gao C; Du H; Guo T; Han J; Huangfu L; Cheng X; Ji J
    Cancer Manag Res; 2019; 11():7877-7891. PubMed ID: 31686906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).
    Yue MM; Lv K; Meredith SC; Martindale JL; Gorospe M; Schuger L
    J Biol Chem; 2014 Dec; 289(49):33971-83. PubMed ID: 25336651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis.
    Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer.
    Ren H; Mai G; Liu Y; Xiang R; Yang C; Su W
    Front Oncol; 2021; 11():644156. PubMed ID: 33996561
    [No Abstract]   [Full Text] [Related]  

  • 13. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
    Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
    Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
    Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
    Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
    Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
    Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EIF3B promotes cancer progression in pancreatic cancer.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells.
    Choi YJ; Lee YS; Lee HW; Shim DM; Seo SW
    Bone Joint Res; 2017 Mar; 6(3):186-193. PubMed ID: 28360085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
    Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
    J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
    Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
    Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.